Blood Test for Alzheimer's Risk Identifies Disease Decades Before Symptoms
Plasma p-tau217 accurately detects preclinical Alzheimer's in cognitively normal adults, potentially enabling earlier intervention.
562 articles in this topic
Plasma p-tau217 accurately detects preclinical Alzheimer's in cognitively normal adults, potentially enabling earlier intervention.
A phase 2 RCT finds ABvac40, a vaccine targeting vascular amyloid-β40, is safe and immunogenic in early Alzheimer's patients with no ARIA-E.
β-endorphin released during exercise wraps around toxic Aβ aggregates, forming a 'corona' that shields brain cells from Alzheimer's damage.
A 19-year cohort study maps how amyloid and tau shift in CSF across the full Alzheimer spectrum, pinpointing the optimal intervention window.
New research overturns assumptions: dolichoectasia, not stenosis, strongly predicts lacunar stroke and cerebral small-vessel disease progression.
A 79-year-old man developed involuntary movements weeks after carotid surgery, revealing a rare stroke complication.
A multinational study finds 56% of genetically diagnosed infants with epilepsy have variants potentially amenable to antisense oligonucleotide treatment.
A newly identified glucocorticoid-iron-α-synuclein axis drives anxiety-linked brain changes, opening fresh therapeutic targets.
New research reveals how sleep-like brain waves coordinate memory replay and flexible thinking in real time.
A liver enzyme released during exercise may rejuvenate brain blood vessels and protect against cognitive decline and Alzheimer's pathology.
A large UK Biobank study finds sleep duration, napping, and sleeplessness independently predict white matter damage tied to dementia risk.
A randomized study finds that disclosing financial compensation during recruitment calls lowered consent rates by up to 13 points in Alzheimer's research.